Updated: 16.04.2021
PRESTIGE-AF Study: 48 Participants
Predictive Modelling of Risk Substudy: 24 Participants
Pharmacology Substudy: 7 Participants
Longitudinal Neuroimaging Substudy: 12 Participants
6 Participants:
Site 406 Hospital Universitario Virgen Macarena- Spain
5 Participants:
Site 101 Imperial College Healthcare NHS Trust- UK
4 Participants:
Site 202 Alfried Krupp Krankenhaus Rüttenscheid – Germany
Site 405 Hospital Dr Josep Trueta – Spain
Site 415 Torrecárdenas University Hospital – Spain
3 Participants:
Site 301 Medical University Graz- Austria
2 Participants:
Site 105 Mid Yorkshire Hospitals NHS Trust – UK
Site 112 Northumbria Healthcare NHS Foundation Trust – UK
Site 601 CHUB-Bordeaux – France
Site 209 Medizinische Hochschule Hannover – Germany
Site 218 Universitätsklinikum Tübingen Neurologie – Germany
Site 232 Bezirkskrankenhaus Günzburg – Germany
1 Participant:
Site 106 Hull and East Yorkshire NHS Trust – UK
Site 210 Klinikum Altenburgerland – Germany
Site 214 Johannes Wesling Klinikum – Germany
Site 215 Universitätsklinikum Leipzig AöR – Germany
Site 221 Universitätsklinikum Dresden- Germany
Site 225 Universitätsklinikum Erlangen Neurologische Klinik – Germany
Site 233 Universitätsklinikum Gießen und Marburg, Germany
Site 401 Vall d’Hebron University Hospital
Site 410 Hospital Universitario Virgen del Rocio – Spain
Site 411 Hospital Germans Trias I Pujol Barcelona – Spain
The PRESTIGE-AF clinical trial is registered on clinicaltrials.gov with identifier NCT03996772. The record is updated throughout the study and the results will be published on this registry. The record can be viewed following the Clinical Trials website.
Clinicaltrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine at the National Institutes of Health, and is the largest clinical trials database, holding registrations from over 329,000 trials from 209 countries.
For more information about PRESTIGE-AF clinical trials and patient eligibility, contact us.
